Nasopharyngeal carcinoma (NPC) is rare malignancy worldwide, yet it is prevalent in South part of China, North, Southeast part of Asia and Arctic. The core components in arrears to this exceptional topographical dispersion stay obscure. Although Epstein-Barr virus (EBV) contamination already appeared as per an imperative cause intended for undistinguishable NPC, the EBV itself isn't adequate to the actual cause of carcinoma. Additionally, co-factors, for example, environmental factors & genetic vulnerability might be related with EBV to commence a share in NPC carcinogenesis. Endurance amounts contrast amongst the patients of NPC at the beginning and last phases. Because of nearby relationship among EBV contamination and risk associated with NPC, Biomarkers related with EBV have been utilized for primary position and NPC evaluation in a couple of extraordinary-occurrence regions. Many vaccines and therapeutic trials also have been performed on patients with NPC. The most recent clinical updates and therapeutic trials have been discussed in this review article.
Authors: Anam Yousaf, Jaweria Pervaiz, Anam Farzand, Ahmad Muneeb
DOI: https://doi.org/10.64813/ejmr.2025.009
Publish Year: 2025
